N.v. Nutricia

Johan Garssen

Bernd Stahl

Günther Boehm

Alma Jildou Nauta

Laura M'Rabet

Jan Knol

Eric Samain

Christopher Beermann

Adrianus Johannes Maria Vriesema

Martine Sandra Alles

Monique Haarman

Saskia Braber

Gelske Speelmans

George Verlaan

Eric Alexander Franciscus Van Tol

Sophie Drouillard

Léon Mathieu Johannes Knippels

Elisabeth Catharina Adriana Maria Van Esch

Leon Matthieu Johannes Knippels

Sander Hougee

Arjan Paul Vos

Marko Mank

Johannes Wilhelmus Christina Sijben

Belinda Potappel-Van 't Land

Nana Bartke

Caroline Schlumprecht

Claudia Traidl-hoffmann

Jeroen Van Bergenhenegouwen

Ruurd Van Elburg

Selma Paulien Wiertsema

Belinda Potappel - Van 't Land

Virginie Sophie Christelle Tregoat

Raymonde Peter Peeters

Antony William Scammell

Johanna Fink-Gremmels

Hermiena Christina Schoterman

Aletta Desiree Kraneveld

Catharina Theresia Knipping

Astrid Hogenkamp

Laura Antoinette Petronella Maria Meulenbroek

Belinda Potappel - Van 'T Land

Kaouther Ben Amor

Francisco José PÉREZ Cano

Laura Antoinette Petronella Maria Neulenbroek

Joost Willem Gouw

Laura M'rabet

Adrianus Johannes Vriesema

Anthony William Scammell

Guenther Boehm

Juandy Jo

The invention relates to the use of beta1,3'-galactosyllactose for improving the gut barrier function. This can in particular be administered to subjects at risk for increased gut barrier permeability, preferably infants and young children.

Beta-1,3'-galactosyllactose for the treatment of gut barrier function diseases

The present invention relates to the use of non-digestible oligosaccharides for the direct attenuation of nasal epithelial inflammation, in particular for non-allergic rhinitis, in particular for use in infants.

Composition with non-digestible oligosaccharides for attenuating nasal epithelial inflammation

The invention pertains to the use of a probiotic and a beta-lactoglobulin-derived peptide in the manufacture of a product for use in inducing oral tolerance, and/or treatment, prevention or reducing the risk of allergy in a subject, in particular cow's milk protein allergy.

Method for inducing oral tolerance via administration of beta-lactoglobulin derived peptides in combination with probiotic

The invention concerns nutritional compositions with fucosyllactose for use in stimulation of NK cells. The composition is suitable for infants.

Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit

Nutritional compositions with fucosyllactose and betagalactooligosaccharides for use in stimulation of the immune system. The composition is suitable for infants.

Mixture of non-digestible oligosaccharides for stimulating the immune system

Disclosed is a nutritional composition comprising a combination of non-digestible oligosaccharides and a product obtained by incubating an aqueous substrate by bifidobacteria and optionally a product obtained by incubating an aqueous substrate by. Said combination synergistically improves the immune system by stimulating the Th1 response, and/or decreasing the Th2 response, improving the vaccination response, improving the resistance against infections and/or decreasing allergy.

Immune system stimulating nutrition

A composition comprising, a non-digestible saccharide A and a non-digestible saccharide B, optionally combined withand the use of said composition for the treatment and/or prevention of gastro-intestinal disorder, immune disorder and/or endocrine disorder.

Nutritional composition with probiotics

The invention relates to nutritional compositions withand non-digestible oligosaccharides selected from the group consisting of fructo-oligosaccharides, galacto-oligosaccharides, gluco-oligosaccharides, arabino-oligosaccharides, mannan-oligosaccharides, xylo-oligosaccharides, fuco-oligosaccharides, arabinogalacto-oligosaccharides, glucomanno-oligosaccharides, galactomanno-oligosaccharides, sialic acid comprising oligosaccharides and uronic acid oligosaccharides for use in improving cognitive or behavioral performance, cognitive or behavioral development, social interaction and/or neuroinflammation in infants or toddlers. Also claimed is the use of a nutritional compositions including, at least one non digestible oligosaccharide, glutamine in the form of free amino acids and/or glutamine containing dipeptide and/or glutaime containing tripeptide and LC-PUFA in the form or arachidonic acid and/or docosahexaenoic acid. Also claimed is a kit of parts comprising a first container comprising glutamine, and a non-digestible oligosaccharide and a second container comprising

Synbiotics combination for brain improvement

An infant and/or toddler nutrition comprising non-viableand a non-digestible oligosaccharide and its use are disclosed.

Nutrition with non-viable bifidobacterium and nondigestible oligosaccharide

We describe a composition comprising a non-digestible oligosaccharide for the treatment, prevention or alleviation of a trichothecene mycotoxin exposure associated condition. The non-digestible oligosaccharide may comprise a galactooligosaccharide and/or fructooligosaccharide. The non-digestible oligosaccharide may comprise a short chain galacto-oligosaccharide (scGOS) and/or short chain fructooligosaccharide (scFOS). The trichothecene mycotoxin exposure associated condition may be associated with exposure to deoxynivalenol.

Treatment of conditions associated with mycotoxin exposure

Compositions and methods for providing infant nutrition with partially hydrolysed proteins and non-digestible oligosaccharides for use in induction of oral tolerance against native dietary proteins.

Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins

The present invention provides a method and composition for the treatment and/or prevention of respiratory tract infection and/or respiratory tract infection disease, said method comprising orally administering a composition to a mammal, said composition comprising a galactose containing indigestible oligosaccharide and at least 5 wt. % digestible galactose saccharide.

Nutritional composition comprising indigestible oligosaccharides

[object Object]

Growing community of inventors

Utrecht, Netherlands

Johan Garssen